Indraprastha Medical Corporation Limited has announced a postal ballot notice seeking shareholder approval for key board appointments through an exclusive e-voting process. The company has issued the notice under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Postal Ballot Resolutions

The company is seeking approval for four special resolutions related to Independent Director appointments:

E-Voting Schedule

The company has established a comprehensive timeline for the postal ballot process:

Director Re-appointments

Mr. Salil Singhal currently serves as an Independent Director until 7th February, 2026, and is proposed for re-appointment for a second five-year term from 8th February, 2026 to 7th February, 2031. As Chairman Emeritus of PI Industries Ltd., he brings over five decades of industry experience across agrochemicals, fine chemicals, and electronic metering solutions.

Ms. Vineeta Rai, IAS (Retd., 1968 batch), holds office as Independent Director until 7th February, 2026. Her proposed re-appointment covers the period from 8th February, 2026 to 7th February, 2031. She brings extensive experience in public administration, particularly in health administration and finance.

Ms. Madhumita Ganguli serves as Independent Director until 8th June, 2026, with her proposed re-appointment spanning from 9th June, 2026 to 8th June, 2031. She is a member of the Executive Management of HDFC Ltd. with over 38 years of experience in legal affairs, business operations, and real estate.

New Director Appointment

Mr. Harsh Pati Singhania was appointed as Additional Director effective 3rd February, 2026, and is now seeking shareholder approval for his appointment as Independent Director for five consecutive years from 3rd February, 2026 to 2nd February, 2031. He serves as Chairman and Managing Director of JK Paper Ltd. and holds an MBA from the University of Massachusetts.

Voting Process and Compliance

In accordance with MCA circulars, the company will not send hard copies of postal ballot notices. Shareholders must vote exclusively through the e-voting system provided by NSDL. The company has appointed Mr. Baldev Singh Kashtwal, Practicing Company Secretary (Membership No. FCS 3616), as Scrutinizer for the postal ballot process.

All proposed resolutions require special resolution approval and, if passed by requisite majority, shall be deemed to have been passed on 20th March, 2026. The results will be announced simultaneously to stock exchanges and made available on the company's website and NSDL's e-voting portal.

Indraprastha Medical Corporation Limited has announced its unaudited financial results for the quarter and nine months ended December 31, 2025. The healthcare company, operating under the Apollo Hospitals brand in Delhi, reported steady operational performance during the period under review.

Financial Performance Overview

The company's financial results for Q3FY26 show total income from operations of ₹378.76 crore, compared to ₹330.06 crore in the corresponding quarter of the previous year. Net profit after tax for the quarter stood at ₹41.00 crore, representing an increase from ₹32.81 crore in Q3FY25.

Nine-Month Performance

For the nine-month period ended December 31, 2025, Indraprastha Medical Corporation achieved total income from operations of ₹1159.12 crore, marking growth from ₹1038.91 crore in the corresponding period of the previous year. The company's net profit after tax for the nine-month period reached ₹141.92 crore, compared to ₹119.98 crore in the same period last year.

Earnings and Capital Structure

The company's earnings per share for Q3FY26 stood at ₹4.47, while the nine-month EPS reached ₹15.48. The paid-up equity share capital remained stable at ₹91.67 crore with a face value of ₹10 per share. Total comprehensive income for the nine-month period was ₹144.38 crore.

Board Approval and Compliance

The financial results were approved by the Board of Directors and are in compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has published the results in Financial Express and Jansatta newspapers as per regulatory requirements. Complete financial results are available on stock exchange websites and the company's official website.

The results demonstrate the company's continued operational stability in the healthcare sector, with consistent revenue generation and profitability across both quarterly and nine-month periods.